BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23770493)

  • 1. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.
    Westergaard RP; Hess T; Astemborski J; Mehta SH; Kirk GD
    AIDS; 2013 Oct; 27(16):2559-66. PubMed ID: 23770493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.
    Westergaard RP; Kirk GD; Richesson DR; Galai N; Mehta SH
    Clin Infect Dis; 2011 Oct; 53(7):725-31. PubMed ID: 21890777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported antiretroviral therapy in injection drug users.
    Celentano DD; Vlahov D; Cohn S; Shadle VM; Obasanjo O; Moore RD
    JAMA; 1998 Aug; 280(6):544-6. PubMed ID: 9707145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use.
    Shannon K; Kerr T; Milloy MJ; Anema A; Zhang R; Montaner JS; Wood E
    AIDS; 2011 Oct; 25(16):2037-42. PubMed ID: 21811140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.
    Westergaard RP; Ambrose BK; Mehta SH; Kirk GD
    J Int AIDS Soc; 2012 Feb; 15(1):10. PubMed ID: 22360788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Nance RM; Delaney JAC; Simoni JM; Wilson IB; Mayer KH; Whitney BM; Aunon FM; Safren SA; Mugavero MJ; Mathews WC; Christopoulos KA; Eron JJ; Napravnik S; Moore RD; Rodriguez B; Lau B; Fredericksen RJ; Saag MS; Kitahata MM; Crane HM
    Ann Intern Med; 2018 Sep; 169(6):376-384. PubMed ID: 30140916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
    Carrieri MP; Villes V; Raffi F; Protopopescu C; Preau M; Salmon D; Taieb A; Lang JM; Verdon R; Chene G; Spire B;
    Int J Drug Policy; 2007 Aug; 18(4):288-95. PubMed ID: 17689377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
    Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
    HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.
    Milloy MJ; Kerr T; Buxton J; Rhodes T; Guillemi S; Hogg R; Montaner J; Wood E
    J Infect Dis; 2011 May; 203(9):1215-21. PubMed ID: 21459814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
    Tyndall MW; McNally M; Lai C; Zhang R; Wood E; Kerr T; Montaner JG
    Int J Drug Policy; 2007 Aug; 18(4):281-7. PubMed ID: 17689376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication therapy among intravenous drug users (IDUs) with HIV infection.
    Smith PC; Page JB
    AIDS Patient Care STDS; 1996 Apr; 10(2):101-10. PubMed ID: 11361686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition issues in the HIV-infected injection drug user: findings from the nutrition for healthy living cohort.
    Hendricks KM; Erzen HD; Wanke CA; Tang AM
    J Am Coll Nutr; 2010 Apr; 29(2):136-43. PubMed ID: 20679149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.